|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:CEO
|
gptkb:José_(Joe)_E._Almeida
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:foundedYear
|
1931
|
|
gptkbp:founder
|
gptkb:Donald_Baxter
|
|
gptkbp:headquartersLocation
|
gptkb:Deerfield,_Illinois,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Baxter Healthcare
|
|
gptkbp:industry
|
gptkb:insurance
Medical devices
Pharmaceuticals
|
|
gptkbp:notableEvent
|
Acquisition of Hillrom in 2021
Spin-off of Baxalta in 2015
|
|
gptkbp:notableProduct
|
Anesthesia products
Hemodialysis machines
Parenteral nutrition
Peritoneal dialysis solutions
Plasma-based therapies
|
|
gptkbp:numberOfEmployees
|
~50,000
|
|
gptkbp:parentCompany
|
gptkb:Baxter_International
|
|
gptkbp:product
|
Biopharmaceuticals
IV solutions
Renal care products
Surgical products
Infusion systems
|
|
gptkbp:revenue
|
$15.1 billion (2022)
|
|
gptkbp:servesArea
|
Worldwide
|
|
gptkbp:stockExchange
|
gptkb:NYSE
|
|
gptkbp:stockSymbol
|
gptkb:BAX
|
|
gptkbp:subsidiary
|
gptkb:Baxter_International
|
|
gptkbp:website
|
https://www.baxter.com
|
|
gptkbp:bfsParent
|
gptkb:Silicone_breast_implant_litigation
|
|
gptkbp:bfsLayer
|
6
|